Muscle-specific Pten deletion protects against insulin resistance and diabetes

被引:196
作者
Wijesekara, N
Konrad, D
Eweida, M
Jefferies, C
Liadis, N
Giacca, A
Crackower, M
Suzuki, A
Mak, TW
Kahn, CR
Klip, A
Woo, M
机构
[1] Ontario Canc Inst, Div Cell & Mol Biol, Toronto, ON M5G 2N9, Canada
[2] Hosp Sick Children, Cell Biol Programme, Toronto, ON M5G 1X8, Canada
[3] Univ Toronto, Dept Physiol, Toronto, ON, Canada
[4] Adv Med Discoveries Inst, Toronto, ON, Canada
[5] St Michaels Hosp, Toronto, ON M5B 1W8, Canada
[6] Amgen Inc, Thousand Oaks, CA 91320 USA
[7] Akita Univ, Sch Med, Dept Biochem, Akita 010, Japan
[8] Harvard Univ, Sch Med, Div Res, Joslin Diabet Ctr, Boston, MA USA
[9] Harvard Univ, Sch Med, Dept Med, Boston, MA USA
关键词
D O I
10.1128/MCB.25.3.1135-1145.2005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pten (phosphatase with tensin homology), a dual-specificity phosphatase. is a negative regulator or the phosphoinositide 3-kinase (PI3K)/Akt signaling pathway. Pten regulates a vast array or biological functions; including growth, metabolism, and longevity. Although the PI3K/Akt pathway is a key determinant of the insulin-dependent increase in glucose uptake into muscle and adipose cells. the contribution or this pathway in muscle to whole-body glucose homeostasis is unclear. Here we show that muscle-specific deletion of Pten protected mice from insulin resistance and diabetes caused by high-fat feeding. Deletion of muscle Pten resulted in enhanced insulin-stimulated 2-deoxyglucose uptake and Akt phosphorylation in soleus but. surprisingly, not in extensor digitorum longus muscle compared to littermate controls upon high-fat feeding, and these mice were spared from developing hyperinsulinemia and islet hyperplasia. Muscle Pten may be a potential target for treatment or prevention of insulin resistance and diabetes.
引用
收藏
页码:1135 / 1145
页数:11
相关论文
共 51 条
[1]   Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease [J].
Backman, SA ;
Stambolic, V ;
Suzuki, A ;
Haight, J ;
Elia, A ;
Pretorius, J ;
Tsao, MS ;
Shannon, P ;
Bolon, B ;
Ivy, GO ;
Mak, TW .
NATURE GENETICS, 2001, 29 (04) :396-403
[2]   Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten [J].
Backman, SA ;
Ghazarian, D ;
So, K ;
Sanchez, O ;
Wagner, KU ;
Hennighausen, L ;
Suzuki, A ;
Tsao, MS ;
Chapman, WB ;
Stambolic, V ;
Mak, TW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (06) :1725-1730
[3]   PTEN function in mammalian cell size regulation [J].
Backman, SA ;
Stambolic, V ;
Mak, TW .
CURRENT OPINION IN NEUROBIOLOGY, 2002, 12 (05) :516-522
[4]   A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance [J].
Bruning, JC ;
Michael, MD ;
Winnay, JN ;
Hayashi, T ;
Horsch, D ;
Accili, D ;
Goodyear, LJ ;
Kahn, CR .
MOLECULAR CELL, 1998, 2 (05) :559-569
[5]   Specific inhibition of PTEN expression reverses hyperglycemia in diabetic mice [J].
Butler, M ;
McKay, RA ;
Popoff, IJ ;
Gaarde, WA ;
Witchell, D ;
Murray, SF ;
Dean, NM ;
Bhanot, S ;
Monia, BP .
DIABETES, 2002, 51 (04) :1028-1034
[6]   PHOSPHATIDYLINOSITOL 3-KINASE ACTIVATION IS REQUIRED FOR INSULIN STIMULATION OF PP70 S6 KINASE, DNA-SYNTHESIS, AND GLUCOSE-TRANSPORTER TRANSLOCATION [J].
CHEATHAM, B ;
VLAHOS, CJ ;
CHEATHAM, L ;
WANG, L ;
BLENIS, J ;
KAHN, CR .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (07) :4902-4911
[7]   Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B [J].
Cheng, A ;
Uetani, N ;
Simoncic, PD ;
Chaubey, VP ;
Lee-Loy, A ;
McGlade, CJ ;
Kennedy, BP ;
Tremblay, ML .
DEVELOPMENTAL CELL, 2002, 2 (04) :497-503
[8]   Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKBβ) [J].
Cho, H ;
Mu, J ;
Kim, JK ;
Thorvaldsen, JL ;
Chu, QW ;
Crenshaw, EB ;
Kaestner, KH ;
Bartolomei, MS ;
Shulman, GI ;
Birnbaum, MJ .
SCIENCE, 2001, 292 (5522) :1728-1731
[9]   The lipid phosphatase SHIP2 controls insulin sensitivity [J].
Clément, S ;
Krause, U ;
Desmedt, F ;
Tanti, JF ;
Behrends, J ;
Pesesse, X ;
Sasaki, T ;
Penninger, J ;
Doherty, M ;
Malaisse, W ;
Dumont, JE ;
Le Marchand-Brustel, Y ;
Erneux, C ;
Hue, L ;
Schurmans, S .
NATURE, 2001, 409 (6816) :92-97
[10]   Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways [J].
Crackower, MA ;
Oudit, GY ;
Kozieradzki, I ;
Sarao, R ;
Sun, H ;
Sasaki, T ;
Hirsch, E ;
Suzuki, A ;
Shioi, T ;
Irie-Sasaki, J ;
Sah, R ;
Cheng, HYM ;
Rybin, VO ;
Lembo, G ;
Fratta, L ;
Oliveira-dos-Santos, AJ ;
Benovic, JL ;
Kahn, CR ;
Izumo, S ;
Steinberg, SF ;
Wymann, MP ;
Backx, PH ;
Penninger, JM .
CELL, 2002, 110 (06) :737-749